Status:
TERMINATED
Discontinuation Order of Vasopressors in Septic Shock
Lead Sponsor:
Samsung Medical Center
Conditions:
Septic Shock
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the incidence of hypotension based on the discontinuation order of norepinephrine and vasopressin in patients receiving concomitant norepinephrine and vasopres...
Detailed Description
There are little data regarding the discontinuation of vasopressors in patients with septic shock. Therefore, the investigators intend to evaluate the incidence of hypotension based on the discontinua...
Eligibility Criteria
Inclusion
- patients 20 years of age or older
- patients of receiving concomitant therapy with norepinephrine and vasopressin for teh management of septic shock
- patients began to reduce the vasopressor
Exclusion
- patients who expired or had care withdrawn while receiving norepinephrine and vasopressin
- patients being transferred into the ICU from an outside facility or the operating room
- patients who are suspected to have vasopressin deficiency (eg. HPA axis dysfunction, empty sella)
- acute myocardial infarction or Congestive heart failure (NYHA functional classification III or IV)
- acute mesenteric ischemia
- patients who were received other vasopressor except for norepinephrine or vasopressin
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT01493102
Start Date
December 1 2011
End Date
December 1 2013
Last Update
January 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710